In the BioHarmony Drug Report Database

"Preview" Icon

Rifamycin

Aemcolo (rifamycin) is a small molecule pharmaceutical. Rifamycin was first approved as Aemcolo on 2018-11-16. It is known to target solute carrier organic anion transporter family member 1A2, solute carrier organic anion transporter family member 2B1, solute carrier organic anion transporter family member 1B1, and solute carrier organic anion transporter family member 1B3. Aemcolo’s patent is valid until 2025-05-03 (FDA).

 

Trade Name

 

Aemcolo
 

Common Name

 

rifamycin
 

ChEMBL ID

 

CHEMBL437765
 

Indication

 

 

Drug Class

 

Antibiotics (Streptomyces strains); antibiotics (rifamycin derivatives)

Image (chem structure or protein)

Rifamycin structure rendering